<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00770016</url>
  </required_header>
  <id_info>
    <org_study_id>LM_HYPO_2008</org_study_id>
    <nct_id>NCT00770016</nct_id>
  </id_info>
  <brief_title>Insulin Sensitivity and Metabolism Before and After Treatment in Patients With Hypothyroidism</brief_title>
  <official_title>Insulin Sensitivity and Metabolism Before and After Treatment in Patients With Hypothyroidism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MR Research Center, Skejby Sygehus, Brendstrupgaardsvej 100, 8200 Aarhus N</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to further characterize the treatment related changes in insulin
      sensitivity, substrate metabolism and intra hepatic- and intramyocellular lipid content in
      patients with hypothyroidism
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    no longer interested in doing the study
  </why_stopped>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">January 2011</completion_date>
  <primary_completion_date type="Anticipated">January 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intracellular lipid content in liver and muscle</measure>
    <time_frame>before and after 3 months treatment with growth hormone</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>intraabdominal lipid content</measure>
    <time_frame>before and after treatment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>insulin sensitivity</measure>
    <time_frame>before and after treatment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>substrate metabolism</measure>
    <time_frame>before and after treatment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>intracellular signaling in the basal state and during insulin stimulation</measure>
    <time_frame>before and after treatment</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Hypothyroidism</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the aim of the present study is to characterize the treatment related changes in insulin sensitivity, substrate metabolism and intrahepatic - intramyocellular lipids in 12 adult patients, recently diagnosed with hypothyroidism</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levothyroxin</intervention_name>
    <description>Dosage regulation will follow the local recommendations of treatment</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Eltroxin (Levothyroxin, GlaxoSmithKline Pharma)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  written informed consent

          -  must be of legal age and competent

          -  Age &gt; 18 years

          -  presently diagnosed with hypothyroidism

        Exclusion Criteria:

          -  alcohol consumption &gt;21 units per week

          -  Malignant disease

          -  pregnancy

          -  magnetic implants or material in the body

          -  BMI &gt; 30

          -  Heart disease (NYHA &gt;2)

          -  Uncontrolled hypertension

          -  Manifest diabetes mellitus

          -  Changes in medication, with any influence on glucose metabolism, 2 months prior to and
             until the end of the trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medical department M (Endocrinology and Diabetes), Aarhus University Hospital, Aarhus Sygehus,</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://person.au.dk/da/joj@afdm.au.dk/act</url>
    <description>(Jens Otto Lunde Jorgensen)</description>
  </link>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 8, 2008</study_first_submitted>
  <study_first_submitted_qc>October 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 9, 2008</study_first_posted>
  <last_update_submitted>October 25, 2010</last_update_submitted>
  <last_update_submitted_qc>October 25, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2010</last_update_posted>
  <responsible_party>
    <name_title>Jens Otto Lunde Jorgensen</name_title>
    <organization>Medical Department M, Aarhus University Hospital, Aarhus Sygehus, Norrebrogade 44, 8000 Aarhus C</organization>
  </responsible_party>
  <keyword>insulin sensitivity</keyword>
  <keyword>Substrate metabolism</keyword>
  <keyword>Fatty liver</keyword>
  <keyword>intramyocellular lipid</keyword>
  <keyword>intracellular signaling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Hypothyroidism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

